Title : Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.

Pub. Date : 2001 Feb

PMID : 11180504






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson"s disease. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytochrome c oxidase II, mitochondrial Mus musculus
2 To study the possible role of the isoenzymes of cyclooxygenase COX-1 and COX-2 in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson"s disease we used acetylsalicylic acid, a COX-1/COX-2 inhibitor, in comparison with meloxicam, a preferential COX-2 inhibitor. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytochrome c oxidase II, mitochondrial Mus musculus
3 To study the possible role of the isoenzymes of cyclooxygenase COX-1 and COX-2 in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson"s disease we used acetylsalicylic acid, a COX-1/COX-2 inhibitor, in comparison with meloxicam, a preferential COX-2 inhibitor. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytochrome c oxidase II, mitochondrial Mus musculus
4 To study the possible role of the isoenzymes of cyclooxygenase COX-1 and COX-2 in the MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson"s disease we used acetylsalicylic acid, a COX-1/COX-2 inhibitor, in comparison with meloxicam, a preferential COX-2 inhibitor. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytochrome c oxidase II, mitochondrial Mus musculus
5 In conclusion, the inhibition of either COX-1/COX-2 by acetylsalicylic acid or preferentially COX-2 by meloxicam provided a clear neuroprotection against MPTP-toxicity on the striatal and nigral levels. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytochrome c oxidase II, mitochondrial Mus musculus